Development of hepatic fibrosis occurs normally in AMPK-deficient mice (Q43255957)

17 November 2017

Development of hepatic fibrosis occurs normally in AMPK-deficient mice (English)

1 reference

17 November 2017

4

1 reference

17 November 2017

Bruno Guigas

3

0 references

Alain da Silva Morais

object named as

Alain da Silva Morais

1

0 references

author name string

Jorge Abarca-Quinones

2

1 reference

17 November 2017

Peter Stärkel

5

1 reference

17 November 2017

Yves Horsmans

6

1 reference

17 November 2017

Isabelle A Leclercq

7

1 reference

17 November 2017

language of work or name

English

0 references

publication date

14 December 2009

1 reference

17 November 2017

1 reference

17 November 2017

118

1 reference

17 November 2017

6

1 reference

17 November 2017

411-420

1 reference

Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin

17 November 2017

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

AMP-activated protein kinase: balancing the scales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

AMP-activated protein kinase induces a p53-dependent metabolic checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

Leptin is essential for the hepatic fibrogenic response to chronic liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

Prevention of steatohepatitis by pioglitazone: implication of adiponectin-dependent inhibition of SREBP-1c and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

TSC2 mediates cellular energy response to control cell growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

AMPK, the metabolic syndrome and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

Expression and regulation of cell adhesion molecules by hepatic stellate cells (HSC) of rat liver: involvement of HSC in recruitment of inflammatory cells during hepatic tissue repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

Contraction regulation of Akt in rat skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

AMPK phosphorylation of raptor mediates a metabolic checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

AMPK: an emerging drug target for diabetes and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

AMP-activated protein kinase inhibits transforming growth factor-beta-induced Smad3-dependent transcription and myofibroblast transdifferentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

The role of Smad3 in mediating mouse hepatic stellate cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

5-Aminoimidazole-4-Carboxamide-1- -D-Ribofuranoside and Metformin Inhibit Hepatic Glucose Phosphorylation by an AMP-Activated Protein Kinase-Independent Effect on Glucokinase Translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090293

21 January 2018

Identifiers

DOI

10.1042/CS20090293

1 reference

17 November 2017

1 reference